Annual Total Long Term Liabilities
$192.84 M
+$56.54 M+41.48%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total long term liabilities is $192.84 million, with the most recent change of +$56.54 million (+41.48%) on December 31, 2023.
- During the last 3 years, CTNM annual total long term liabilities has risen by +$55.10 million (+40.00%).
- CTNM annual total long term liabilities is now at all-time high.
Performance
CTNM Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$113.00 K-100.00%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total long term liabilities is $0.00, with the most recent change of -$113.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, CTNM quarterly long term liabilities has dropped by -$192.84 million (-100.00%).
- CTNM quarterly long term liabilities is now -100.00% below its all-time high of $192.96 million, reached on March 31, 2024.
Performance
CTNM Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CTNM Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.5% | -100.0% |
| 3 y3 years | +40.0% | -100.0% |
| 5 y5 years | +40.0% | -100.0% |
CTNM Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.5% | -100.0% | at low |
| 5 y | 5-year | at high | +41.5% | -100.0% | at low |
| alltime | all time | at high | +41.5% | -100.0% | at low |
Contineum Therapeutics Class A Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $113.00 K(-99.9%) |
| Mar 2024 | - | $192.96 M(+0.1%) |
| Dec 2023 | $192.84 M | $192.84 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $192.75 M(+41.4%) |
| Dec 2022 | $136.30 M(-1.0%) | - |
| Dec 2022 | - | $136.30 M |
| Dec 2021 | $137.74 M | - |
FAQ
- What is Contineum Therapeutics Class A annual total long term liabilities?
- What is the all time high annual total long term liabilities for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual total long term liabilities year-on-year change?
- What is Contineum Therapeutics Class A quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly long term liabilities year-on-year change?
What is Contineum Therapeutics Class A annual total long term liabilities?
The current annual total long term liabilities of CTNM is $192.84 M
What is the all time high annual total long term liabilities for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total long term liabilities is $192.84 M
What is Contineum Therapeutics Class A annual total long term liabilities year-on-year change?
Over the past year, CTNM annual total long term liabilities has changed by +$56.54 M (+41.48%)
What is Contineum Therapeutics Class A quarterly total long term liabilities?
The current quarterly long term liabilities of CTNM is $0.00
What is the all time high quarterly long term liabilities for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total long term liabilities is $192.96 M
What is Contineum Therapeutics Class A quarterly long term liabilities year-on-year change?
Over the past year, CTNM quarterly total long term liabilities has changed by -$192.84 M (-100.00%)